pharmaceutical

Florricks Lifecare Expands Global Footprint with USD 95 Million Investment in Europe and Hong Kong

Florricks Lifecare Private Limited, a leading research-driven global pharmaceutical company renowned for its innovative R&D, production, and sales of Active…

1 month ago

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia

TOKYO & HAYWARD, Calif.--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Arcus Biosciences, Inc. (NYSE:RCUS, “Arcus”) announced that Taiho exercised its…

1 month ago

Not Just Pharmacy: How Medkart is Building India's Smartest Generic Medicine App

India’s pharmaceutical landscape is undergoing a vital transformation. Despite being home to one of the world’s largest medicine markets, millions…

1 month ago

LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood

ANDERNACH, Germany, Oct. 13, 2025 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company today announces the…

1 month ago

MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients

NEW DELHI, Oct. 9, 2025 /PRNewswire/ -- MSN Laboratories, a leading global Indian pharmaceutical company, today announced that it is…

1 month ago

AscellaHealth Leaders Take the Stage at SIIA National Conference: Present Strategies for Managing High-Cost Claims and Building Pharma Partnerships

BERWYN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical…

2 months ago

Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer

Board-certified oncologist who brings over 20 years of senior clinical development experience across large pharmaceutical, biotechnology and Clinical Research OrganizationsLONDON--(BUSINESS…

2 months ago

Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases

Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional…

2 months ago

Viva Biotech Receives Frost & Sullivan’s 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation…

2 months ago

Artelo Biosciences Announces Proposed Underwritten Public Offering

September 29, 2025 19:15 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

2 months ago